Live feed16:33:50·279dINSIDERFilingvia QuantisnowEVP, Chief Development Officer Poulton Stuart was granted 888 shares and sold $2,578 worth of shares (401 units at $6.43), increasing direct ownership by 2% to 27,710 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.KPTI· Karyopharm Therapeutics Inc.Health CareOriginal source